ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

4 hedge funds and large institutions have $1.07M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

99% less call options, than puts

Call options by funds: $2K | Put options by funds: $258K

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$258K
Net Calls
Net Calls Change

Top Buyers

1
+$519K
2
+$145K
3
+$72K

Top Sellers

1
-$360K
2
-$328K
3
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$519K
2
$339K
3
$145K
4
$72K
5
–
6
–